Enzymatic functionalization of a nanobody using protein insertion technology. Issue 10 (6th April 2015)

• Record Type: Journal Article
• Authors: Crasson, O.; Rhazi, N.; Jacquin, O.; Freichels, A.; Jérôme, C.; Ruth, N.; Galleni, M.; Filée, P.; Vandevenne, M.
• Is Part Of: Protein engineering, design & selection. Volume 28:Issue 10(2015)
• Page Start: 451
• Page End: 460
• Publication Date: 2015-04-06
• Subjects: antibody engineering -- β-lactamase -- multifunctional enzyme -- nanobody -- protein chimera; Protein engineering -- Periodicals; 660.63
• DOI: 10.1093/protein/gzv020
• Languages: English
• ISSNs: 1741-0126

Abstract

Abstract : Antibody-based products constitute one of the most attractive biological molecules for diagnostic, medical imagery and therapeutic purposes with very few side effects. Their development has become a major priority of biotech and pharmaceutical industries. Recently, a growing number of modified antibody-based products have emerged including fragments, multi-specific and conjugate antibodies. In this study, using protein engineering, we have functionalized the anti-hen egg-white lysozyme (HEWL) camelid VHH antibody fragment (cAb-Lys3), by insertion into a solvent-exposed loop of the Bacillus licheniformis β-lactamase BlaP. We showed that the generated hybrid protein conserved its enzymatic activity while the displayed nanobody retains its ability to inhibit HEWL with a nanomolar affinity range. Then, we successfully implemented the functionalized cAb-Lys3 in enzyme-linked immunosorbent assay, potentiometric biosensor and drug screening assays. The hybrid protein was also expressed on the surface of phage particles and, in this context, was able to interact specifically with HEWL while the β-lactamase activity was used to monitor phage interactions. Finally, using thrombin-cleavage sites surrounding the permissive insertion site in the β-lactamase, we reported an expression system in which the nanobody can be easily separated from its carrier protein. Altogether, our study shows that insertion into the BlaP β-lactamase constitutes a suitable technology to functionalize nanobodies and allows the creation of versatile tools that can be used in innovative biotechnological assays.